| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 64,028,000 | 84,696,000 | 137,737,000 | 138,072,000 | | Cost of Revenue | 36,124,000 | 47,926,000 | 83,579,000 | 87,099,000 | | | Gross Profit | 27,904,000 | 36,770,000 | 54,158,000 | 50,973,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,154,000 | 19,676,000 | 24,139,000 | 25,345,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,793,000 | 3,177,000 | 3,008,000 | 3,090,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,957,000 | 13,917,000 | 27,011,000 | 22,538,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 7,957,000 | 13,313,000 | 26,475,000 | 22,313,000 | | Interest Expense | 107,000 | 118,000 | 318,000 | 107,000 | | Income Before Tax | 7,850,000 | 13,195,000 | 26,157,000 | 22,206,000 | | Income Tax Expense | 3,148,000 | 5,375,000 | 11,327,000 | 10,526,000 | | Minority Interest |
-
| (604,000) | (536,000) | (225,000) | | | | Net Income From Continuing Ops | 4,702,000 | 7,820,000 | 14,830,000 | 11,680,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,702,000 | 7,820,000 | 14,830,000 | 11,680,000 | | Preferred Stock And Other Adjustments | (152,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,550,000 | $7,820,000 | $14,830,000 | $11,680,000 |
|
3.07% Nasdaq 
Income Statement
